Envestnet Asset Management Inc. Has $101.78 Million Position in Aflac Incorporated $AFL

Envestnet Asset Management Inc. cut its stake in shares of Aflac Incorporated (NYSE:AFL) by 19.3% during the 3rd quarter, Holdings Channel reports. The fund owned 911,185 shares of the financial services provider’s stock after selling 218,503 shares during the period. Envestnet Asset Management Inc.’s holdings in Aflac were worth $101,779,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AFL. Vanguard Personalized Indexing Management LLC grew its stake in Aflac by 11.9% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 93,449 shares of the financial services provider’s stock valued at $9,856,000 after purchasing an additional 9,907 shares during the period. Nordea Investment Management AB boosted its holdings in shares of Aflac by 3.8% in the 3rd quarter. Nordea Investment Management AB now owns 1,768,705 shares of the financial services provider’s stock worth $196,662,000 after buying an additional 65,308 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in Aflac by 12.2% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 90,976 shares of the financial services provider’s stock valued at $10,162,000 after buying an additional 9,878 shares during the period. Rakuten Investment Management Inc. purchased a new stake in Aflac during the third quarter worth about $1,117,000. Finally, Oregon Public Employees Retirement Fund raised its position in Aflac by 31.0% in the third quarter. Oregon Public Employees Retirement Fund now owns 55,022 shares of the financial services provider’s stock worth $6,146,000 after acquiring an additional 13,017 shares during the period. 67.44% of the stock is owned by institutional investors.

Aflac News Summary

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: Revenue beat estimates—Aflac reported Q4 revenue above consensus, reflecting strong top-line performance that offsets some earnings weakness. AFLAC ($AFL) Releases Q4 2025 Earnings
• Positive Sentiment: Company is boosting shareholder returns—Aflac’s quarter included actions to increase returns to shareholders, which supports the dividend/repurchase narrative. Aflac Reports Mixed Q4 Results, Boosts Shareholder Returns
• Positive Sentiment: Management set 2026 benefit-ratio targets and signaled continued capital deployment—this implies confidence in margin trends (especially in Japan) and potential for ongoing buybacks/dividends. Aflac outlines 2026 benefit ratio targets and signals continued strong capital deployment
• Neutral Sentiment: Full earnings materials available—investors have access to the earnings presentation and detailed call transcript to parse reserves, investment income and segment trends. Aflac Incorporated 2025 Q4 – Results – Earnings Call Presentation
• Negative Sentiment: EPS missed consensus—Q4 GAAP EPS came in below estimates ($1.57 vs. ~ $1.69–$1.71), pressured by lower investment income and higher costs, which is the immediate driver of downward price pressure. Aflac Q4 Earnings Miss Estimates on Lower Investment Income
• Negative Sentiment: Cybersecurity fallout and management commentary raised investor concerns—coverage highlights how post-earnings commentary and cyber-related issues could influence sentiment and near-term stock performance. How Investors May Respond To Aflac (AFL) Earnings Amid Cybersecurity Fallout And Management Commentary
• Negative Sentiment: Analyst mix and insider selling—several firms have low or underweight ratings and recent insider sales plus a median analyst target below the current price add downward pressure. AFLAC ($AFL) Releases Q4 2025 Earnings

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the stock. Wells Fargo & Company increased their target price on shares of Aflac from $107.00 to $109.00 and gave the company an “equal weight” rating in a research report on Friday, November 7th. Morgan Stanley set a $120.00 price objective on Aflac in a report on Monday, December 15th. Barclays set a $101.00 target price on Aflac and gave the stock an “underweight” rating in a research report on Thursday, January 8th. TD Cowen reaffirmed a “hold” rating on shares of Aflac in a research report on Monday, December 22nd. Finally, Raymond James Financial reissued an “outperform” rating and issued a $119.00 price objective (up previously from $110.00) on shares of Aflac in a report on Tuesday, December 30th. Three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $110.64.

Aflac Stock Performance

Shares of AFL opened at $117.19 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.11 and a current ratio of 0.11. The stock has a market capitalization of $61.42 billion, a price-to-earnings ratio of 17.03, a price-to-earnings-growth ratio of 3.48 and a beta of 0.67. Aflac Incorporated has a 52-week low of $96.95 and a 52-week high of $119.32. The stock’s 50-day simple moving average is $110.11 and its 200 day simple moving average is $108.69.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $1.57 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.12). Aflac had a net margin of 21.24% and a return on equity of 14.35%. The company had revenue of $4.87 billion for the quarter, compared to the consensus estimate of $4.45 billion. During the same quarter in the prior year, the company earned $1.57 earnings per share. The company’s quarterly revenue was down 9.6% on a year-over-year basis. Research analysts forecast that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Wednesday, February 18th will be issued a $0.61 dividend. This represents a $2.44 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Wednesday, February 18th. This is a positive change from Aflac’s previous quarterly dividend of $0.58. Aflac’s payout ratio is 33.72%.

Insider Activity

In related news, EVP Steven Kent Beaver sold 5,492 shares of Aflac stock in a transaction on Friday, December 12th. The stock was sold at an average price of $109.53, for a total transaction of $601,538.76. Following the completion of the sale, the executive vice president owned 38,368 shares of the company’s stock, valued at approximately $4,202,447.04. This trade represents a 12.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Joseph L. Moskowitz sold 786 shares of the company’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $113.75, for a total value of $89,407.50. Following the completion of the transaction, the director owned 24,829 shares in the company, valued at $2,824,298.75. This represents a 3.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 29,044 shares of company stock worth $3,241,981 in the last three months. Corporate insiders own 0.90% of the company’s stock.

Aflac Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.